Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Pharmacogenetics of selective serotonin reuptake inhibitors (SSRI): A serotonin reuptake transporter (SERT)-based approach.

Neurochemistry international - 1 Feb 2024

Sreeja V, Jose Anju, Patel Shashikant, Menon Bindu, Athira K V, Chakravarty Sumana

Abstract excerpt

Neuropsychiatric disorders are considered to be the most common cause of disability worldwide. Serotonin and its transporter is a prominent paradigm in mood disorders. Response to selective serotonin reuptake inhibitors (SSRI) is altered due to heterogeneity in the serotonin transporter gene, SLC6A4 (solute carrier family 6 member 4). The reported polymorphisms are found to be in different regions of the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Pharmacogenetics
Share to Polymorphism, Single Nucleotide

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Selective Serotonin Reuptake Inhibitors

Share to Serotonin

Share to Serotonin Plasma Membrane Transport Proteins

Source

Identifiers

PMID: 38157886
DOI: 10.1016/j.neuint.2023.105672

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Pharmacogenetics of selective serotonin reuptake inhibitors (SSRI): A serotonin reuptake transporter (SERT)-based approach.PMID 38157886Read ↗

Serotonin Transporter Gene Polymorphisms and Selective Serotonin Reuptake Inhibitor Tolerability: Review of Pharmacogenetic EvidenceSemantic proximity Read ↗

Polymorphism of rs3813034 in Serotonin Transporter Gene SLC6A4 Is Associated With the Selective Serotonin and Serotonin-Norepinephrine Reuptake Inhibitor Response in Depressive Disorder: Sequencing Analysis of SLC6A4.Semantic proximity Read ↗

Polymorphisms of serotonin neurotransmission and their effects on antipsychotic drug action.Semantic proximity Read ↗

Monoamine transporter gene polymorphisms affect susceptibility to depression and predict antidepressant response.Semantic proximity Read ↗

The role of pharmacogenetics in the treatment of depression and anxiety disorders.Semantic proximity Read ↗

Understanding the pharmacogenetics of selective serotonin reuptake inhibitors.Semantic proximity Read ↗

The influence of 5-HTTLPR and STin2 polymorphisms in the serotonin transporter gene on treatment effect of selective serotonin reuptake inhibitors in depressive patients.Semantic proximity Read ↗

Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6, CYP2C19, CYP2B6, SLC6A4, and HTR2A Genotypes and Serotonin Reuptake Inhibitor Antidepressants.Semantic proximity Read ↗

Simultaneous genotyping of multiple polymorphisms in human serotonin transporter gene and detection of novel allelic variants.Semantic proximity Read ↗

Development and validation of a high-throughput screening method for two polymorphisms in the serotonin transporter gene.Semantic proximity Read ↗

Evidence of association of serotonin transporter gene polymorphisms with schizophrenia in a South Indian population.Semantic proximity Read ↗

Serotonin transporter: gene, genetic disorders, and pharmacogenetics.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.